109. Atypical hemolytic uremic syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 114 / Drugs : 36 - (DrugBank : 7) / Drug target genes : 3 - Drug target pathways : 11
Atypical hemolytic uremic syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 109 | Atypical hemolytic uremic syndrome | - |
| 66 | IgA nephropathy | 3.000 |
| 222 | Primary nephrotic syndrome | 3.000 |
| 62 | Paroxysmal nocturnal hemoglobinuria | 1.397 |
| 61 | Autoimmune hemolytic anemia | 1.387 |